We are delighted to announce that 4Moving Biotech has been selected as one of the top 100 startups to invest in 2024 by the prestigious economic magazine Challenges.
As a young startup, we are proud of this recognition. It underscores the unique potential of our company to innovate in the research and development of a revolutionary therapeutic solution for people with knee osteoarthritis.
We want to express our gratitude to our fantastic team, partners, and you and our community for your continued support.
To learn more about our vision, mission, and impact, we invite you to read the full article on Challenges:
